PFIZER REPORTS FIRST-QUARTER 2015 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Pfizer (PFE) Tops Q1 EPS by 2c, Lowers FY Guidance Due to Exchange Rates
April 28, 2015 7:05 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $0.51, $0.02 better than the analyst estimate of $0.49. Revenue for the quarter came in at $10.86 billion versus the consensus estimate of $10.79 billion.
Pfizer's 2015 financial guidance was updated solely to reflect changes in foreign exchange rates in relation to the U.S. dollar from mid-January 2015 to mid-April 2015, primarily the weakening of the euro.
Pfizer sees FY2015 EPS of $1.95-$2.05, versus prior guidance of $2.00-$2.10 and the consensus of $2.07. Pfizer sees FY2015 revenue of $44-46 million, versus prior guidance of $44.5-46.5 million and the consensus of $45.94... More
